Literature DB >> 1672972

Calcium antagonist caution.

.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1672972

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Pulse wave mechanics revisited: relevance to therapy of cardiovascular disease with calcium antagonists.

Authors:  M F O'Rourke
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

Review 2.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

3.  Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.

Authors:  P Omvik; P Lund-Johansen
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

4.  Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial.

Authors:  P A Woodmansey; A G Stewart; A H Morice; K S Channer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure.

Authors:  T Takahashi; P D Allen; R V Lacro; A R Marks; A R Dennis; F J Schoen; W Grossman; J D Marsh; S Izumo
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 6.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

7.  Comparison of nisoldipine and nifedipine as additional treatment in hypertension inadequately controlled by atenolol.

Authors:  B I Hoffbrand; K A Earle; J G Nievel; L J Restrick; N J Simmonds
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.